2 2) Modulation of the nitric-oxide (NO) system & vascular tone Ex vivo aorta studies show BPC-157 modulates vasomotor tone in an NO-dependent manner, likely via SrcCav-1eNOS interactions that increase NO generation
A 2018 study in Dermatologic Therapy found that 38% of patients experienced rebound hyperpigmentation within 812 weeks of discontinuing hydroquinone monotherapy, likely because melanocytes compensate for reduced tyrosinase activity by upregulating MITF (microphthalmia-associated transcription factor), the master regulator of melanocyte differentiation
Ferroptotic therapy in cancer: benefits, side effects, and risks
What are the reported side effects of peptides in BPC-157 studies
To view a copy of this licence, visit About this article Cite this article Hecht, F., Zocchi, M., Tuttle, E.T